Laparoscopic cholecystectomy
Conditions
Interventions
Dexamethasone group (Group D):Dexamethasone 5mg intravenously was administered 30 minutes before anesthesia
The group treated with press-needle combined with dexamethasone (QD group):30 minutes before anesthesia, 5mg of dexamethasone was injected intravenally, and bilateral Neiguan and Zusanli points were s
Intradermal Needle Group (Group Q):30 minutes before anesthesia, the press needle was used to stimulate the bilateral Neiguan and Zusanli points, and the needle was left for 48 hours
The blank group (Group K):Administer 5 ml of normal saline during anesthesia induction
Sponsors
The People's Hospital of Hechi
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) ASA Grade I to II (2) NYHA Grade I to II (3) patients aged 18 to 75 years; (4) Body Mass Index (BMI) 18.5~27.9kg/m2 (based on the body mass index of overweight and obese adults in China); (5) Surgical method: laparoscopic cholecystectomy; (6) Voluntary signing of informed consent for anesthesia.
Exclusion criteria
Exclusion criteria: (1) general anesthesia drug allergy (2) dexamethasone allergy (3) acupuncture point infection or rupture; (4) Abnormal coagulation function; (5) Metabolic diseases; (6) Long-term use of sedative and analgesic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bowel movement and flatus status at 24 hours post-surgery; | — |
Countries
China
Contacts
Public ContactTanXinMei
Teaching secretary
Outcome results
None listed